Cantitate/Preț
Produs

Progress in Radiopharmacy: Developments in Nuclear Medicine, cartea 22

Editat de August P. Schubiger, Gerrit Westera
en Limba Engleză Hardback – 31 dec 1991

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 133174 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 25 sep 2012 133174 lei  6-8 săpt.
Hardback (1) 133849 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 31 dec 1991 133849 lei  6-8 săpt.

Din seria Developments in Nuclear Medicine

Preț: 133849 lei

Preț vechi: 140893 lei
-5% Nou

Puncte Express: 2008

Preț estimativ în valută:
25621 27547$ 21359£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792315254
ISBN-10: 0792315251
Pagini: 228
Ilustrații: XIII, 228 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.53 kg
Ediția:1992
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

1. Future development of radiopharmaceuticals.- One: Brain receptor ligands.- 2. Necessary conditions for a multicenter study with a new radiopharmaceutical. Example: 123 I-Iomazenil.- 3. Design and evaluation of new receptor ligands exemplified by recent developments in the pharmacology of the benzodiazepine receptor.- 4. Studies on substituted benzamides as brain dopamine receptor imaging agent.- Two: Technetium-99m and other radionuclide generators.- 5. Cell labeling in radiopharmacy: what can radiolabeled monoclonal antibodies offer?.- 6. Automated systems for the preparation of Tc-kits in hospitals.- 7. New radiopharmaceuticals based on Technetium.- 8. The development of new radionuclide generator systems for nuclear medicine applications.- Three: Positron Emission Tomography.- 9. Production and application of oxygen-15; radiopharmacy aspects.- 10. Clinical aspects of positron emission tomography.- 11. Carbon-11 radiopharmaceuticass - radiopharmacy aspects.- 12. Production and distribution of 18F-radiopharmaceuticals - 2-deoxy-2[18F]fluoro-D-Glucose — radiopharmaceutic aspects.- 13. Preclinical data necessary to assess PET examinations.- Four: Rules and regulations.- 14. EEC directives and radiopharmaceuticals: the point of view of the radiopharmaceutical industry.- 15. European regulations and guidelines for the registration of radiopharmaceuticals.- 16. General guidelines for the quality assurance and quality control of short-lived radiopharmaceuticals.- 17. Legal and regulatory aspects of PET radiopharmaceuticals in the USA.- Five: Education.- 18. The development of a co-ordinated training programme in radiopharmacy in Europe.- 19. Experiences in postgraduate education of radiochemists and radiopharmacists at Berlin- Buch.- Six: Appendix.- 20. Monoclonalchimeric antibodies to HIV-1 - Clinical perspectives.- 21. Tracer technique - the Swiss story.

Recenzii

'...results in a publication that should serve as a useful resource for radioharmacists, radiopharmaceutical scientists, and nuclear medicine clinicians working in academic and research environments.' Clinical Nuclear Medicine Sep. 1992